| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Serge Saxonov
Also a director
Chief Executive Officer and Director
|
49 | Not stated | $6,329,244 | |
|
Adam S. Taich
Chief Financial Officer
|
51 |
Since 2024
2 years
|
$2,233,107 | |
|
Benjamin J. Hindson
Also a director
See Remarks
Title from the Form 4 dated Aug 24, 2026
|
51 | Not stated | $2,604,759 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Nov 2, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
John R. Stuelpnagel
Board chair
|
68 |
2013
13 years
|
Independent |
audit committee
compensation committee
mergers and acquisitions committee
|
None stated | $283,413 | |
|
Serge Saxonov
CEO
|
49 |
2012
14 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Benjamin J. Hindson
Executive officer
|
51 |
2012
14 years
|
Not stated | None stated | None stated | Not stated | |
|
Alan Mateo
|
64 |
2024
2 years
|
Independent |
audit committee
compensation committee
nominating and corporate governance committee
|
None stated | $208,273 | |
|
Kimberly J. Popovits
|
67 |
2020
6 years
|
Independent |
audit committee
compensation committee
|
Kiniksa Pharmaceuticals, Ltd., Exact Sciences | $216,323 | |
|
Sarah Teichmann
|
50 |
2024
2 years
|
Independent | None stated | None stated | $198,323 | |
|
Sri Kosaraju
|
48 |
2019
7 years
|
Independent |
mergers and acquisitions committee
|
None stated | $223,323 | |
|
Shehnaaz Suliman
|
54 |
2019
7 years
|
Independent |
mergers and acquisitions committee
nominating and corporate governance committee
|
Ultragenyx Pharmaceutical Inc. | $210,994 | |
|
Ansuman Satpathy
Joined Oct 28, 2026
|
- | - | - | - | - | - | |
|
Joseph Gilliam
Joined Oct 28, 2026
|
- | - | - |
Audit Committee · Chair
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 24, 2026 states there were none.
Read it in the proxyLoading...